Related Experiment Video
Updated: Nov 8, 2025

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.7K
Extrapulmonary Tuberculosis masquerading as chest wall malignancy: Just never ceases to surprise!
Mousa Hussein1, Ahmad Abdelhadi2, Anam Elarabi1
1Pulmonary Department, Hamad General Hospital, Qatar.
Idcases
|April 26, 2021
Summary
Tuberculosis incidence increased with acquired immunodeficiency syndrome, often affecting extrapulmonary sites. This case highlights isolated chest wall tuberculosis in an immunocompetent individual, emphasizing diagnostic challenges.
Area of Science:
- Infectious Diseases
- Pulmonology
- Medical Case Reports
Background:
- The emergence of acquired immunodeficiency syndrome (AIDS) has correlated with a rise in disseminated and extrapulmonary tuberculosis cases.
- Extrapulmonary tuberculosis commonly affects lymph nodes, pleura, and osteoarticular sites, but can involve any organ.
- Atypical presentations of extrapulmonary tuberculosis present significant diagnostic challenges for clinicians.
Observation:
- This report details a rare case of isolated tuberculosis affecting the chest wall.
- The patient was immunocompetent, underscoring that tuberculosis can occur outside of typical risk groups.
- The isolated nature of the chest wall involvement highlights the diverse clinical manifestations of tuberculosis.
Findings:
- The case demonstrates that tuberculosis can manifest as isolated chest wall disease.
- Diagnostic vigilance is crucial, especially in tuberculosis-endemic regions, due to the potential for atypical presentations.
- This presentation underscores the need for a broad differential diagnosis when evaluating chest wall masses or pain.
Implications:
- Clinicians should maintain a high index of suspicion for tuberculosis, even in immunocompetent patients presenting with seemingly localized symptoms.
- Enhanced diagnostic strategies may be required to identify extrapulmonary tuberculosis, particularly in endemic areas.
- Understanding rare presentations like isolated chest wall tuberculosis improves diagnostic accuracy and patient outcomes.
Keywords:
Chest wall massCold abscessExtrapulmonary tuberculosisMusculoskeletal tuberculosisRib fractureMore Related Videos
Related Concept Videos
Pulmonary Tuberculosis III
568
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
568
Pulmonary Tuberculosis IV
257
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
257
Pulmonary Tuberculosis II
802
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
802
Pulmonary Tuberculosis I
451
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
451
Other Pulmonary Disorders
1.1K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.1K
Pneumothorax-II
567
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
567

